You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Pancreas Ductal Adenocarcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

Recruiting
  • Bile Duct Adenocarcinoma
  • surufatinib plus cadonilimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 15, 2023

Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreas Adenocarcinoma, Peritoneal Metastases Trial in Quebec City (Whole-body

Recruiting
  • Pancreas Cancer, Duct Cell Adenocarcinoma
  • +3 more
  • Whole-body diffusion-weighted magnetic resonance imaging
  • Quebec City, Quebec, Canada
    CHU de Québec
Apr 20, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Nanoliposomal irinotecan
  • +3 more
  • Brugge, West-Vlaanderen, Belgium
  • +11 more
Jul 25, 2022

Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)

Not yet recruiting
  • Pancreas Adenocarcinoma
  • Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 2, 2023

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

Active, not recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

Genetic, Microenvironmental, and Immunological Factors in

Recruiting
  • Pancreas Cancer
    • Rome, Lazio, Italy
      "Agostino Gemelli" Hospital, Catholic University of Sacred Heart
    Apr 4, 2022

    Pancreas Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Los Angeles (Ketorolac Tromethamine)

    Recruiting
    • Pancreas Cancer
    • +2 more
    • Ketorolac Tromethamine
    • Los Angeles, California
      Cedars- Sinai Medical Center
    Jul 15, 2022

    Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

    Active, not recruiting
    • Pancreatic Cancer
    • +2 more
    • Nab-paclitaxel and gemcitabine for R-PDAC Patients
    • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
    • Scottsdale, Arizona
    • +3 more
    Mar 8, 2022

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)

    Active, not recruiting
    • Adenocarcinoma of the Pancreas
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Jul 7, 2022

    CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)

    Not yet recruiting
    • CYP3A Inhibitor
    • Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
    • Cobicistat Oral Tablet
    • Heidelberg, BW, Germany
      University Hospital Heidelberg
    Aug 10, 2022

    Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +3 more
    • (no location specified)
    May 22, 2023

    Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)

    Completed
    • Cancer of Pancreas
    • +2 more
    • Gemcitabine fluorouracil
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University, Faculty of medicine
    Aug 5, 2022

    Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)

    Not yet recruiting
    • Adenocarcinoma of the Pancreas
    • Valproic acid
    • +4 more
    • Milano, Italy
    • +4 more
    Apr 6, 2023

    Pancreas Cancer, Gastrointestinal Adenocarcinoma Trial in New York (ultrasound)

    Recruiting
    • Pancreas Cancer
    • Gastrointestinal Adenocarcinoma
    • ultrasound
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 12, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Bordeaux, France
    • +7 more
    May 16, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,

    Completed
    • Pancreatic Cancer
    • Pancreatic Ductal Adenocarcinoma
    • Woodville South, South Australia, Australia
    • +2 more
    Oct 26, 2022

    Pancreatic Cancer Recurrence in the Netherlands

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
      • Utrecht, Netherlands
        UMC Utrecht
      Feb 1, 2023

      Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

      Active, not recruiting
      • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
      • Scottsdale, Arizona
        HonorHealth Research Institute
      Feb 15, 2022

      Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

      Not yet recruiting
      • Metastatic Pancreatic Ductal Adenocarcinoma
      • +3 more
      • Biopsy
      • +8 more
      • (no location specified)
      Jan 13, 2023

      Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

      Active, not recruiting
      • Metastatic Pancreatic Adenocarcinoma
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Jan 3, 2023